Literature DB >> 25014437

Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.

Hiroshi Nishioka1, Noriaki Fukuhara, Kentaro Horiguchi, Shozo Yamada.   

Abstract

OBJECT: Cavernous sinus (CS) invasion is the most important preoperative predictor of remission in the surgical treatment of growth hormone-producing pituitary adenomas. The purpose of this study was to evaluate the effectiveness of an aggressive technique for removal of tumors invading the CS in patients with acromegaly.
METHODS: The authors retrospectively reviewed the cases of 150 consecutive patients with acromegaly who underwent primary transsphenoidal surgery in 2010 and 2011. The authors reviewed preoperative Knosp grade, intraoperative findings, histology of the medial wall of the CS, and surgical outcome according to the current consensus criteria for acromegaly.
RESULTS: Cavernous sinus invasion was identified in 55 patients (36.7%): definite CS involvement by the tumor was observed under direct vision in 41 patients (74.5%), while invasion was histologically verified in 39 patients (70.9%). Invasion increased in frequency with the higher Knosp grade but was observed in 14.4% (13 of 90) of Grade 0 and 1 tumors. Overall, the remission rate fulfilling stringent criteria was 84.7% (127 of 150). Although CS invasion was significantly associated with an unfavorable outcome (p < 0.0001), remission was achieved in 69.1% (38 of 55) of patients with invasion. No major complications occurred in this series.
CONCLUSIONS: Cavernous sinus invasion is the most significant, independent predictor of unfavorable outcome. Confirmation of invasion requires direct observation within the CS regardless of the microscope or endoscope used. Particularly in cases in which only the medial wall is involved, histological verification is always necessary to detect the occult invasion. Direct removal of the invading tumor, by sharp excision of the medial wall of the CS, is effective and safe and increases the chance of remission.

Entities:  

Keywords:  CS = cavernous sinus; GH = growth hormone; IGF-I = insulin-like growth factor–I; SD = standard deviation; TSS = transsphenoidal surgery; acromegaly; cavernous sinus invasion; occult invasion; oncology; pituitary adenoma; transsphenoidal surgery

Mesh:

Year:  2014        PMID: 25014437     DOI: 10.3171/2014.3.JNS132214

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

1.  Surgical Treatment of Cavernous Sinus Lesion in Patients with Nonfunctioning Pituitary Adenomas via the Endoscopic Endonasal Approach.

Authors:  Masahiro Toda; Kenzo Kosugi; Hiroyuki Ozawa; Kaoru Ogawa; Kazunari Yoshida
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

2.  Predictors of surgical outcome and early criteria of remission in acromegaly.

Authors:  Ximene Antunes; Nina Ventura; Gustavo Bittencourt Camilo; Luiz Eduardo Wildemberg; Andre Guasti; Paulo José M Pereira; Aline Helen Silva Camacho; Leila Chimelli; Paulo Niemeyer; Mônica R Gadelha; Leandro Kasuki
Journal:  Endocrine       Date:  2018-04-06       Impact factor: 3.633

3.  Critical analysis of anatomical landmarks within the sphenoid sinus for transsphenoidal surgery.

Authors:  Yahya Ahmadipour; Elias Lemonas; Homajoun Maslehaty; Sophia Goericke; Boris A Stuck; Nicolai El Hindy; Ulrich Sure; Oliver Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-21       Impact factor: 2.503

4.  Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission.

Authors:  Marcelo Lemos Vieira da Cunha; Luis Alencar Biurrum Borba; Cesar Luiz Boguszewski
Journal:  Endocrine       Date:  2020-02-20       Impact factor: 3.633

5.  Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.

Authors:  Yuichi Nagata; Naoko Inoshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Hiroshi Nishioka; Takeo Iwata; Katsuhiko Yoshimoto; Shozo Yamada
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 6.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

7.  Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.

Authors:  Amy A Swanson; Dana Erickson; Diane Mary Donegan; Sarah M Jenkins; Jamie J Van Gompel; John L D Atkinson; Bradley J Erickson; Caterina Giannini
Journal:  Pituitary       Date:  2020-10-19       Impact factor: 4.107

8.  Cavernous Sinus Involvement by Pituitary Adenomas: Clinical Implications and Outcomes of Endoscopic Endonasal Resection.

Authors:  Abdulrazag Ajlan; Achal S Achrol; Abdulrahman Albakr; Abdullah H Feroze; Erick M Westbroek; Peter Hwang; Griffith R Harsh
Journal:  J Neurol Surg B Skull Base       Date:  2017-01-23

9.  Peel-off resection of the pituitary gland for functional pituitary adenomas: pathological significance and impact on pituitary function.

Authors:  Yuichi Nagata; Kazuhito Takeuchi; Taiki Yamamoto; Takayuki Ishikawa; Teppei Kawabata; Yoshie Shimoyama; Naoko Inoshita; Toshihiko Wakabayashi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

10.  The role of multimodal navigation in endoscopic endonasal surgery for giant pituitary adenomas.

Authors:  Chen Yang; Jiarui Zhang; Jianzhong Li; Nan Wu; Dong Jia
Journal:  Gland Surg       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.